Multivariable Mendelian randomization adjusting for HDL and triglycerides shows LDL retains an independent causal effect on cardiovascular risk
3 events · 1 assessment · 1 decision
Structured and assessed
First pass. Reviewed the claim's neighborhood (LDL-causation cluster, all live and largely settled) and its single parent, the pleiotropy claim it supports. Judged the claim a specific, well-settled empirical finding best left atomic: what would undermine it (LDL's MVMR estimate attenuating to null after HDL/TG adjustment) is a single direct empirical question, and the candidate subclaims either restate the claim or already exist as siblings, so no decomposition added value. Set importance 0.32 (notable, low contestation): a supporting methodological premise in a well-developed literature where LDL's independent effect is not disputed. Assessed VERIFIED (conf 0.88, credence 0.93) on direct reading of the primary MVMR literature (White 2016 JAMA Cardiology; Holmes 2015 EHJ; a reproduced Scientific Reports 2020 MVMR analysis), which consistently shows LDL's estimate stable to HDL/TG adjustment while HDL's collapses. Noted the apoB reframing (Richardson 2020) as an interpretive refinement, not a contradiction, since it conditions on apoB rather than HDL/TG. Confidence held under 0.9 as the verdict rests on published estimates, not reanalysis.
Assessed Verified
verdict confidence 0.88 · credence 0.93
Multivariable Mendelian randomization, which estimates the effect of each lipid fraction while conditioning simultaneously on the others, consistently finds that LDL cholesterol retains a strong, statistically significant causal association with cardiovascular disease after adjustment for HDL cholesterol and triglycerides. This is a robust and reproduced result: across the major MVMR analyses of coronary artery disease, LDL's estimated effect is essentially undiminished by the adjustment, whereas the apparent protective association of HDL cholesterol largely collapses toward the null once LDL and triglycerides are accounted for. The finding is a central reason the causal role of LDL is considered secure while that of HDL is not. One refinement qualifies the interpretation rather than the claim. Later work modelling apolipoprotein B (apoB), the particle count carried by LDL and other atherogenic lipoproteins, suggests apoB may be the more proximate causal quantity: when analyses condition on apoB, the independent effects of LDL cholesterol and triglycerides attenuate. This does not overturn the result stated here, which concerns adjustment for HDL and triglycerides and under which LDL's effect persists; it recasts LDL cholesterol as a strong marker of the atherogenic-particle burden that drives risk. What would weaken the claim is MVMR evidence showing LDL's estimate falling to the null specifically after conditioning on HDL and triglycerides, which the literature does not show.
Claim entered the graph